ES8800273A1 - Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria - Google Patents

Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria

Info

Publication number
ES8800273A1
ES8800273A1 ES553425A ES553425A ES8800273A1 ES 8800273 A1 ES8800273 A1 ES 8800273A1 ES 553425 A ES553425 A ES 553425A ES 553425 A ES553425 A ES 553425A ES 8800273 A1 ES8800273 A1 ES 8800273A1
Authority
ES
Spain
Prior art keywords
carrier protein
vaccine against
protein conjugate
against malaria
immunogenic antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553425A
Other languages
English (en)
Spanish (es)
Other versions
ES553425A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of ES553425A0 publication Critical patent/ES553425A0/es
Publication of ES8800273A1 publication Critical patent/ES8800273A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES553425A 1985-03-28 1986-03-26 Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria Expired ES8800273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71696085A 1985-03-28 1985-03-28

Publications (2)

Publication Number Publication Date
ES553425A0 ES553425A0 (es) 1987-11-01
ES8800273A1 true ES8800273A1 (es) 1987-11-01

Family

ID=24880143

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553425A Expired ES8800273A1 (es) 1985-03-28 1986-03-26 Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria

Country Status (9)

Country Link
EP (1) EP0216901A4 (ja)
JP (1) JPS62502340A (ja)
AU (1) AU5695686A (ja)
ES (1) ES8800273A1 (ja)
IE (1) IE860846L (ja)
IL (1) IL78292A0 (ja)
PT (1) PT82282B (ja)
WO (1) WO1986005790A1 (ja)
ZA (1) ZA862376B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
US5225530A (en) * 1986-07-16 1993-07-06 Eniricerche S.P.A. Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT1196501B (it) * 1986-07-16 1988-11-16 Eniricerche Spa Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche
EP0289110A3 (en) * 1987-02-02 1990-01-24 Swiss Serum and Vaccine Institute Berne Conjugate malaria vaccine
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
IT8820888A0 (it) * 1988-06-08 1988-06-08 Eniricerche Spa Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.
IT1226728B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344613A (en) * 1976-09-30 1978-04-21 Eisai Co Ltd Tumor vaccine containing lectin/tumor cell-complex
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein

Also Published As

Publication number Publication date
ES553425A0 (es) 1987-11-01
JPS62502340A (ja) 1987-09-10
IL78292A0 (en) 1986-07-31
EP0216901A4 (en) 1989-10-04
AU5695686A (en) 1986-10-23
PT82282A (en) 1986-04-01
ZA862376B (en) 1986-11-26
PT82282B (pt) 1988-02-17
EP0216901A1 (en) 1987-04-08
IE860846L (en) 1986-09-28
WO1986005790A1 (en) 1986-10-09

Similar Documents

Publication Publication Date Title
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
PT82975A (en) Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein and of vaccine against the malaria
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
NZ233085A (en) Eimeria tenella 100kd immunogenic peptide, vectors, antibodies and vaccines
NZ215023A (en) Vaccine against plasmodium falciparum and antigenic peptides
NZ223174A (en) Peptides and multimers immunologically related to circumsporozoite protein; vaccines against plasmodium falciparum-induced malaria
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
SE9002684D0 (sv) New peptides and their use
ES2006730A6 (es) Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
EP0392820A3 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences
IL92774A (en) Vaccines having as active ingredient a peptide comprising a repetitive amino acid sequence of the immunodominant epitope of plasmodium circumsporozoite protein
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
SE8702698L (sv) Polypeptid, anvendbar for framstellning av antimalariavacciner och diagnostest for pavisande av malariasjukdomar
IE861786L (en) Immunogenic peptide antigen corresponding to plasmodium¹vivaz circumsporozoite protein
DE216901T1 (de) Immunogenes antigen-traeger-proteinkonjugat zur verwendung in impfstoffen gegen malaria.
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519